在心房的患者中,diltiazem的疗效和CYP2D6基因多态性与快速心室反应
Mehmet Uluturk1, Atakan Yilmaz2, Murat Seyit1
1Department of Emergency Medicine, Faculty of Medicine, Pamukkale University, 20070, Denizli, Turkey.
概括
在CYP2D6中的遗传变异会影响diltiazem在控制心房动率方面的疗效. 某些CYP2D6等位基因 (*2, *4, *10) 损害药物的有效性,而 *3 显示没有影响.
科学领域:
- 药物基因组学 药物基因组学
- 心脏病学 心脏病学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 迪尔提阿泽姆是对心房的快速心室反应的一线紧急治疗.
- 细胞染色体P450 2D6 (CYP2D6) 代谢了迪尔提亚.
- 在CYP2D6的遗传变异可以改变药物代谢和疗效.
研究的目的:
- 调查CYP2D6遗传多态性和diltiazem在患有心房动和快速心室反应的患者中疗效之间的关联.
主要方法:
- 一组87名心室速率>120bpm的患者接受了静脉注射的迪尔提亚 (0.25 mg/kg,如果需要的话,接着是0.35 mg/kg).
- 心率控制被定义为 < 110 bpm 2 小时.
- 分析了CYP2D6等位基因 (*1个野生类型, *2, *3, *4, *10个变体).
主要成果:
- 野生型 (重量/重量) CYP2D6 载体的控制率明显高于重量/*2,重量/*4 和重量/*10 异体载体.
- 对于重量/*3异体载体,没有观察到速率控制的显著差异.
结论:
- CYP2D6的*2,*4,和*10等位基因显著降低了diltiazem在心房的节率控制方面的疗效.
- 在这种情况下,CYP2D6 *3等位基因似乎不会影响diltiazem的疗效.
更多相关视频
相关概念视频
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
890
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
890
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
781
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
781
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
93
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
93
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.1K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.1K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
51
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
51
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.5K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.5K


